Project Grant K23NS140559
- This federal Project Grant award of $664,458, provided by the National Institute of Neurological Disorders and Stroke (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders), supports research to develop a novel non-invasive optical imaging technique for the prehospital detection of large vessel occlusion (LVO) in acute stroke patients. The University of Pennsylvania, the grant recipient, is validating this optical cerebral hemodynamic monitoring approach...
- The U.S. National Institute of Neurological Disorders and Stroke (NINDS) awarded a $125,685 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Leland Stanford Junior University (Stanford University). The funding will support the development of an injectable hydrogel with an integrated urokinase plasminogen activator (uPA) motif and plasmid DNA (pDNA) platelet-derived growth factor B (PDGFB)-lipoplexes to be loaded into the...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $124,485 to The Leland Stanford Junior University (Stanford University) to develop and test a "Fused Imaging and Large Language Foundational Model (FILLM)" to predict 90-day outcomes for patients with acute ischemic strokes. The project aims to integrate...
- The federal Project Grant award of $619,969.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant aims to develop and validate a real-time AI-powered mobile diagnostic tool called "DEEPSTROKE+" to improve the identification and triage of stroke patients in emergency settings. The research project, conducted by The Methodist Hospital...
- This is a K23 award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $458,005 grant supports a young investigator, Dr. James Giles, in pursuing patient-oriented clinical research on ischemic stroke caused by large vessel occlusion. The funding will enable Dr. Giles to develop expertise in computational biology for transcriptomic analysis of tissue and blood...
- This $490,049 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by Shearit LLC to evaluate the efficacy of their Lamiflo drug for reducing ischemic penumbra and core volumes in acute ischemic stroke. The 1-year study will test Lamiflo, a drag-reducing polymer that enhances blood flow, in rat models of middle cerebral artery...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $299,982 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Unandup, LLC, a technology development firm in St. Louis, Missouri. The grant funding supports the development of the Commercialization Readiness Pilot for the FAST (Flow Acceleration for Stroke Thrombolysis) System, an innovative medical device platform designed to safely accelerate the...
- This $238,410 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS, CFDA 93.853) supports research at the University of California, San Francisco (UCSF) to identify protective and harmful mechanisms of acid-base physiology relevant to ischemic stroke. The project's objective is to determine how adjusting systemic and cerebral levels of carbon dioxide and hydrogen ions can improve metabolic supply, inhibit spreading depolarizations, and reduce stroke size in mouse...
- This $498,995 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) platform for the real-time, non-invasive measurement of cerebral blood flow. The research aims to address the limitations of current stroke diagnosis and monitoring techniques...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $541,109 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Washington. The 5-year grant, beginning January 1, 2025, will fund research to quantify myelin loss and recovery in ischemic stroke patients using a novel magnetic resonance imaging (MRI) technique called single-point macromolecular proton fraction (MPF) mapping. The...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA Program 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders provides $227,475 in funding to the University of California, Davis for a 5-year study led by Dr. Kevin Keenan on prehospital diagnostic testing for large vessel occlusion (LVO) stroke triage. The study aims to develop and validate a new stroke screening test called CLEAR-LVO that combines clinical variables and the Cincinnati Prehospital Stroke Scale to improve identification of LVO stroke compared to existing tests. The project will provide Dr. Keenan with mentored training to become an independent stroke emergency medical services researcher, including expertise in areas such as large EMS dataset management, machine learning, and emergency research ethics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $227.5k | 7/30/25 |